Listed

Kura Oncology, Inc.

KURANasdaqCIK 1422143HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$20.9m, Q2 FY2026
Operating income−$73.0m, Q2 FY2026
Net income−$68.3m, Q2 FY2026
Kura Oncology, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported14.1Revenue, Q1 FY2025, three months to 2025-03-31$14.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure15.3Revenue, Q2 FY2025, three months to 2025-06-30$15.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure20.8Revenue, Q3 FY2025, three months to 2025-09-30$20.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure17.3Revenue, Q4 FY2025, three months to 2025-12-31$17.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure18.3Revenue, Q1 FY2026, three months to 2026-03-31$18.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure20.9Revenue, Q2 FY2026, three months to 2026-06-30$20.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported0.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$262.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure0.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$243.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Research and development$m29.3Research and development, Q3 FY2023, three months to 2023-09-30$29.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure32.5Research and development, Q4 FY2023, three months to 2023-12-31$32.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure36.3Research and development, Q1 FY2024, three months to 2024-03-31$36.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure39.7Research and development, Q2 FY2024, three months to 2024-06-30$39.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure41.7Research and development, Q3 FY2024, three months to 2024-09-30$41.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure52.3Research and development, Q4 FY2024, three months to 2024-12-31$52.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure56.0Research and development, Q1 FY2025, three months to 2025-03-31$56.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure62.8Research and development, Q2 FY2025, three months to 2025-06-30$62.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure67.9Research and development, Q3 FY2025, three months to 2025-09-30$67.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure64.4Research and development, Q4 FY2025, three months to 2025-12-31$64.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure65.3Research and development, Q1 FY2026, three months to 2026-03-31$65.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure61.9Research and development, Q2 FY2026, three months to 2026-06-30$61.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported22.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$22.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure25.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$25.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figurenot reportednot reported31.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$31.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure31.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$31.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Operating income$mnot reportednot reported(54.5)Operating income, Q1 FY2024, three months to 2024-03-31−$54.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure(56.4)Operating income, Q2 FY2024, three months to 2024-06-30−$56.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure(59.9)Operating income, Q3 FY2024, three months to 2024-09-30−$59.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure(22.5)Operating income, Q4 FY2024, three months to 2024-12-31−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(64.7)Operating income, Q1 FY2025, three months to 2025-03-31−$64.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(72.7)Operating income, Q2 FY2025, three months to 2025-06-30−$72.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure(80.0)Operating income, Q3 FY2025, three months to 2025-09-30−$80.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure(86.3)Operating income, Q4 FY2025, three months to 2025-12-31−$86.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(78.8)Operating income, Q1 FY2026, three months to 2026-03-31−$78.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(73.0)Operating income, Q2 FY2026, three months to 2026-06-30−$73.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Interest expense$m0.4Interest expense, Q3 FY2023, three months to 2023-09-30$404.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure0.4Interest expense, Q4 FY2023, three months to 2023-12-31$394.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-27, accession 0000950170-24-021094. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2024, three months to 2024-03-31$398.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure0.4Interest expense, Q2 FY2024, three months to 2024-06-30$406.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure0.4Interest expense, Q3 FY2024, three months to 2024-09-30$412.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure0.4Interest expense, Q4 FY2024, three months to 2024-12-31$403.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2025, three months to 2025-03-31$382.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure0.4Interest expense, Q2 FY2025, three months to 2025-06-30$391.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure0.4Interest expense, Q3 FY2025, three months to 2025-09-30$393.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure0.3Interest expense, Q4 FY2025, three months to 2025-12-31$346.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2026, three months to 2026-03-31$336.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure0.3Interest expense, Q2 FY2026, three months to 2026-06-30$345.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reported0.2Income tax, Q1 FY2025, three months to 2025-03-31$226.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-346884. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-263589. Derived: 9-month figure less the 6-month figure.Report this figure0.1Income tax, Q4 FY2025, three months to 2025-12-31$71.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Net income$m(38.6)Net income, Q3 FY2023, three months to 2023-09-30−$38.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure(42.8)Net income, Q4 FY2023, three months to 2023-12-31−$42.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(49.5)Net income, Q1 FY2024, three months to 2024-03-31−$49.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure(50.8)Net income, Q2 FY2024, three months to 2024-06-30−$50.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure(54.4)Net income, Q3 FY2024, three months to 2024-09-30−$54.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure(19.2)Net income, Q4 FY2024, three months to 2024-12-31−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(57.4)Net income, Q1 FY2025, three months to 2025-03-31−$57.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure(66.1)Net income, Q2 FY2025, three months to 2025-06-30−$66.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure(74.1)Net income, Q3 FY2025, three months to 2025-09-30−$74.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure(81.0)Net income, Q4 FY2025, three months to 2025-12-31−$81.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(73.3)Net income, Q1 FY2026, three months to 2026-03-31−$73.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure(68.3)Net income, Q2 FY2026, three months to 2026-06-30−$68.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Diluted EPS$ per share(0.50)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figurenot reported(0.59)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure(0.59)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure(0.63)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figurenot reported(0.66)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(0.75)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure(0.85)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figurenot reported(0.83)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(0.77)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Basic EPS$ per share(0.50)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figurenot reported(0.59)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure(0.59)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure(0.63)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figurenot reported(0.66)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(0.75)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure(0.85)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figurenot reported(0.83)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(0.77)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure

Balance sheet

Cash and equivalents$70.2m, Q2 FY2026
Long-term debt$5.6m, Q2 FY2026
Shareholders' equity$48.4m, Q2 FY2026
Kura Oncology, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m28.7Cash and equivalents, Q3 FY2023, at 2023-09-30$28.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure37.3Cash and equivalents, FY2023, at 2023-12-31$37.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-28, accession 0000950170-25-029975.Report this figure41.5Cash and equivalents, Q1 FY2024, at 2024-03-31$41.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure45.2Cash and equivalents, Q2 FY2024, at 2024-06-30$45.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure49.5Cash and equivalents, Q3 FY2024, at 2024-09-30$49.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure224Cash and equivalents, FY2024, at 2024-12-31$224.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure51.3Cash and equivalents, Q1 FY2025, at 2025-03-31$51.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure81.9Cash and equivalents, Q2 FY2025, at 2025-06-30$81.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure95.3Cash and equivalents, Q3 FY2025, at 2025-09-30$95.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure149Cash and equivalents, FY2025, at 2025-12-31$149.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure39.1Cash and equivalents, Q1 FY2026, at 2026-03-31$39.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure70.2Cash and equivalents, Q2 FY2026, at 2026-06-30$70.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Current assets$m460Current assets, Q3 FY2023, at 2023-09-30$459.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure432Current assets, FY2023, at 2023-12-31$432.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0000950170-25-029975.Report this figure538Current assets, Q1 FY2024, at 2024-03-31$537.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure500Current assets, Q2 FY2024, at 2024-06-30$499.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure463Current assets, Q3 FY2024, at 2024-09-30$463.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure745Current assets, FY2024, at 2024-12-31$744.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure724Current assets, Q1 FY2025, at 2025-03-31$724.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure660Current assets, Q2 FY2025, at 2025-06-30$660.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure621Current assets, Q3 FY2025, at 2025-09-30$620.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure709Current assets, FY2025, at 2025-12-31$708.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure624Current assets, Q1 FY2026, at 2026-03-31$623.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure559Current assets, Q2 FY2026, at 2026-06-30$559.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Total assets$m474Total assets, Q3 FY2023, at 2023-09-30$473.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure449Total assets, FY2023, at 2023-12-31$448.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0000950170-25-029975.Report this figure554Total assets, Q1 FY2024, at 2024-03-31$553.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure515Total assets, Q2 FY2024, at 2024-06-30$515.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure479Total assets, Q3 FY2024, at 2024-09-30$478.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure760Total assets, FY2024, at 2024-12-31$760.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure744Total assets, Q1 FY2025, at 2025-03-31$743.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure682Total assets, Q2 FY2025, at 2025-06-30$682.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure649Total assets, Q3 FY2025, at 2025-09-30$649.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure738Total assets, FY2025, at 2025-12-31$738.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure653Total assets, Q1 FY2026, at 2026-03-31$652.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure588Total assets, Q2 FY2026, at 2026-06-30$587.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Current liabilities$m27.5Current liabilities, Q3 FY2023, at 2023-09-30$27.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure35.3Current liabilities, FY2023, at 2023-12-31$35.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0000950170-25-029975.Report this figure32.3Current liabilities, Q1 FY2024, at 2024-03-31$32.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure33.5Current liabilities, Q2 FY2024, at 2024-06-30$33.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure40.4Current liabilities, Q3 FY2024, at 2024-09-30$40.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure78.7Current liabilities, FY2024, at 2024-12-31$78.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure89.8Current liabilities, Q1 FY2025, at 2025-03-31$89.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure107Current liabilities, Q2 FY2025, at 2025-06-30$107.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure121Current liabilities, Q3 FY2025, at 2025-09-30$121.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure117Current liabilities, FY2025, at 2025-12-31$117.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure101Current liabilities, Q1 FY2026, at 2026-03-31$101.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure118Current liabilities, Q2 FY2026, at 2026-06-30$118.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Total liabilities$m43.8Total liabilities, Q3 FY2023, at 2023-09-30$43.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure51.7Total liabilities, FY2023, at 2023-12-31$51.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0000950170-25-029975.Report this figure48.8Total liabilities, Q1 FY2024, at 2024-03-31$48.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure49.0Total liabilities, Q2 FY2024, at 2024-06-30$49.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure55.1Total liabilities, Q3 FY2024, at 2024-09-30$55.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure347Total liabilities, FY2024, at 2024-12-31$346.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure379Total liabilities, Q1 FY2025, at 2025-03-31$379.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure377Total liabilities, Q2 FY2025, at 2025-06-30$376.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure407Total liabilities, Q3 FY2025, at 2025-09-30$406.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure564Total liabilities, FY2025, at 2025-12-31$564.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure545Total liabilities, Q1 FY2026, at 2026-03-31$544.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure539Total liabilities, Q2 FY2026, at 2026-06-30$539.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Long-term debt$m9.3Long-term debt, Q3 FY2023, at 2023-09-30$9.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure9.3Long-term debt, FY2023, at 2023-12-31$9.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-28, accession 0000950170-25-029975.Report this figure9.4Long-term debt, Q1 FY2024, at 2024-03-31$9.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure8.6Long-term debt, Q2 FY2024, at 2024-06-30$8.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure7.8Long-term debt, Q3 FY2024, at 2024-09-30$7.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure6.9Long-term debt, FY2024, at 2024-12-31$6.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure7.7Long-term debt, Q1 FY2025, at 2025-03-31$7.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure6.5Long-term debt, Q2 FY2025, at 2025-06-30$6.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure5.3Long-term debt, Q3 FY2025, at 2025-09-30$5.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure9.7Long-term debt, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure9.7Long-term debt, Q1 FY2026, at 2026-03-31$9.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure5.6Long-term debt, Q2 FY2026, at 2026-06-30$5.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Current portion of debt$mnot reportednot reportednot reported0.8Current portion of debt, Q2 FY2024, at 2024-06-30$847.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure1.7Current portion of debt, Q3 FY2024, at 2024-09-30$1.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure2.6Current portion of debt, FY2024, at 2024-12-31$2.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure1.9Current portion of debt, Q1 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure3.1Current portion of debt, Q2 FY2025, at 2025-06-30$3.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure4.3Current portion of debt, Q3 FY2025, at 2025-09-30$4.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figurenot reported4.2Current portion of debt, Q2 FY2026, at 2026-06-30$4.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure
Shareholders' equity$m430Shareholders' equity, Q3 FY2023, at 2023-09-30$429.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure397Shareholders' equity, FY2023, at 2023-12-31$397.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-092567.Report this figure505Shareholders' equity, Q1 FY2024, at 2024-03-31$505.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure466Shareholders' equity, Q2 FY2024, at 2024-06-30$466.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure424Shareholders' equity, Q3 FY2024, at 2024-09-30$423.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure414Shareholders' equity, FY2024, at 2024-12-31$413.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure364Shareholders' equity, Q1 FY2025, at 2025-03-31$364.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure305Shareholders' equity, Q2 FY2025, at 2025-06-30$305.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure243Shareholders' equity, Q3 FY2025, at 2025-09-30$242.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure174Shareholders' equity, FY2025, at 2025-12-31$174.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure108Shareholders' equity, Q1 FY2026, at 2026-03-31$107.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure48.4Shareholders' equity, Q2 FY2026, at 2026-06-30$48.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure

Cash flow

Operating cash flow−$62.5m, Q2 FY2026
Capital expenditure$656.0k, Q2 FY2026
Kura Oncology, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(29.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$29.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123363. Derived: 9-month figure less the 6-month figure.Report this figure(34.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$34.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(48.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$48.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure(42.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$42.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105051. Derived: 6-month figure less the 3-month figure.Report this figure(43.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$43.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263589. Derived: 9-month figure less the 6-month figure.Report this figure269Operating cash flow, Q4 FY2024, three months to 2024-12-31$269.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(71.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$71.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(28.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$28.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346884. Derived: 6-month figure less the 3-month figure.Report this figure(80.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$80.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263589. Derived: 9-month figure less the 6-month figure.Report this figure117Operating cash flow, Q4 FY2025, three months to 2025-12-31$117.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure(85.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$85.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure(62.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$62.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346884. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123363. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$84.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105051. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-263589. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2024, three months to 2024-12-31$372.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$292.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure1.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-346884. Derived: 6-month figure less the 3-month figure.Report this figure2.6Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-263589. Derived: 9-month figure less the 6-month figure.Report this figure2.3Capital expenditure, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092567. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$128.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure0.7Capital expenditure, Q2 FY2026, three months to 2026-06-30$656.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-346884. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)88.86m, Q2 FY2026
Kura Oncology, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares66.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3066,889,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-058173.Report this figure68.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3168,403,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0000950170-24-052136.Report this figure69.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3069,795,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093997.Report this figure77.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3077,241,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123363.Report this figure83.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3183,905,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0000950170-25-061848.Report this figure86.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3086,635,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105051.Report this figure87.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3086,950,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure87.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3187,415,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure87.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3087,586,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure87.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3087,645,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263589.Report this figure88.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3188,610,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219481.Report this figure88.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3088,855,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure

Shares outstanding: 88.96mShares outstanding, period not labelled, at 2026-08-0788,960,619 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346884.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.